Eyeing better outcomes in diabetic macular oedema: Clinical insights on the evolving role of corticosteroids
Description
touchEXPERT FOCUS for touchOPHTHALMOLOGY
Listen to a series of interviews with two medical retina specialists and a biomarker expert who will provide their insights into the pathophysiology of diabetic macular oedema (DMO), including the inflammatory mechanisms of disease and how they may impact treatment. The faculty will also consider the clinical utility of optical coherence tomography (OCT) imaging biomarkers and emerging evidence on the evolving role of corticosteroids in the management of DMO.
The experts:
- Prof. Stela Vujosevic, Medical Retina Unit, IRCCS MultiMedica and University of Milan, Milan, Italy
- Prof. Francesco Bandello, University Vita-Salute, San Raffaele Scientific Institute, Milan, Italy
- Prof. Laurent Kodjikian, University of Lyon and Croix-Rousse University Hospital, Lyon, France
This touchPODCAST is for HCPs outside of the UK and USA.
This activity is funded by an independent medical education grant from Alimera Sciences Europe Ltd.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchOPHTHALMOLOGY.com
United States
